Medicare Enrolled

Dr. Russell Silverstein, M.D.

Nephrology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
13154 COIT RD STE 100, Dallas, TX 75240
2143582300
In practice since 2006 (20 years)
NPI: 1063483865 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Silverstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Silverstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Silverstein

Dr. Russell Silverstein is a nephrology in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Silverstein performed 5,570 Medicare services across 465 unique beneficiaries.

Between the years covered by Open Payments, Dr. Silverstein received a total of $189,161 from 39 pharmaceutical and/or device companies across 654 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Silverstein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 4% volume in TX$ $189,161 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,570
Medicare services
Top 4% in TX for nephrology
465
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~278 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Epoetin alfa injection (Retacrit) for anemia4,390$6$44
Office visit, established patient (30-39 min)338$58$175
Office visit, established patient, complex (40-54 min)220$66$250
Dialysis services, 4 or more physician visits per month (20 years or older)178$275$850
Blood count, hemoglobin151$2$12
Drug injection, under skin or into muscle144$10$35
Dialysis services, 2-3 physician visits per month (20 years or older)69$238$750
Blood draw (venipuncture)56$8$12
Flu vaccine administration13$30$34
Flu vaccine, quadrivalent11$76$120
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$189,161
Total received (2018-2024)
Avg $27,023/year across 7 years
Top 2% in TX for nephrology
39
Companies
654
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$159,594 (84.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22,515 (11.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,053 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$41,354
2023
$82,283
2022
$57,041
2021
$2,988
2020
$2,141
2019
$1,727
2018
$1,628

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$50,909
Calliditas Therapeutics US Inc.
$34,582
Travere Therapeutics, Inc.
$23,009
CALLIDITAS THERAPEUTICS US INC.
$22,060
GlaxoSmithKline, LLC.
$17,527
ANI Pharmaceuticals, Inc.
$17,248
AstraZeneca Pharmaceuticals LP
$14,063
Horizon Therapeutics plc
$2,212
AKEBIA THERAPEUTICS INC
$1,726
Fresenius USA Marketing, Inc.
$609
Amgen Inc.
$578
Janssen Pharmaceuticals, Inc
$474
OPKO Pharmaceuticals, LLC
$472
Otsuka America Pharmaceutical, Inc.
$465
Bayer HealthCare Pharmaceuticals Inc.
$427
Alexion Pharmaceuticals, Inc.
$425
Vifor Pharma, Inc.
$309
Aurinia Pharma U.S., Inc.
$300
Bayer Healthcare Pharmaceuticals Inc.
$172
Keryx Biopharmaceuticals, Inc.
$170
Genentech USA, Inc.
$158
Mallinckrodt LLC
$157
Mallinckrodt Enterprises LLC
$157
Novartis Pharmaceuticals Corporation
$148
Ardelyx, Inc.
$110
Novo Nordisk Inc
$89
Relypsa, Inc.
$88
CorMedix Inc.
$70
GENZYME CORPORATION
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
Exeltis, USA Inc.
$64
Amarin Pharma Inc.
$49
Alnylam Pharmaceuticals Inc.
$48
Horizon Pharma plc
$46
Takeda Pharmaceuticals U.S.A., Inc.
$45
Recor Medical Inc
$20
Ultragenyx Pharmaceutical Inc.
$17
Chiesi USA, Inc.
$14
Shire North American Group Inc
$14
Top 3 companies account for 57.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AURYXIA · Auryxia · BENLYSTA · CLEVIPREX · DefenCath · FABRAZYME · FABRY-DISEASE · FARXIGA · Fabhalta · GATTEX · GIVLAARI · IBSRELA · INVOKANA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LIBERTY SELECT CYCLER · LOKELMA · LUPKYNIS · ONPATTRO · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rituxan · Rybelsus · SAMSCA · SOLIRIS · TARPEYO · TAVNEOS · ULTOMIRIS · Uloric · Vascepa · Velphoro · Veltassa · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for nephrology in TX.

Equivalent to $3,396 per 100 Medicare services performed
Looking for a nephrology in Dallas?
Compare nephrologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse nephrologys nearby

Geographic Context

Nephrologys within 10 mi
222
Per 100K population
8.5
County median income
$74,149
Nearest hospital
MEDICAL CITY GREEN OAKS HOSPITAL
1.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Silverstein is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (speaking/promotional, top 2%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Silverstein experienced with epoetin alfa injection (retacrit) for anemia?
Based on Medicare claims data, Dr. Silverstein performed 4,390 epoetin alfa injection (retacrit) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Silverstein receive payments from pharmaceutical companies?
Yes. Dr. Silverstein received a total of $189,161 from 39 companies across 654 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Silverstein's costs compare to other nephrologys in Dallas?
Dr. Silverstein's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Silverstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →